XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.1

Research and Development Costs (Tables)

3 Months Ended

Mar. 31, 2023

Research and Development [Abstract]

Schedule of Research and Development Costs

Research and development costs, including costs associated with clinical trials involving the Company’s lead clinical compound LB-100, are summarized below based on the respective geographical regions where such costs are incurred.

 Schedule of Research and Development Costs

		2023				2022
		Three Months Ended March 31,
		2023				2022
United States		$	135,907			$	74,531
Spain			975				328,829
China			—				860
Netherlands			52,203				54,230
Total		$	189,085			$	458,450
Research and development expense		$	189,085			$	458,450

X

- Definition

Research Development [TableTextBlock]

+ References

No definition available.

+ Details

Name:	LIXT_ResearchDevelopmentTableTextBlock
Namespace Prefix:	LIXT_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration